You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

low risk MDS

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial (Roxadustat in combination with retinoic acid)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Roxadustat in combination with retinoic acid
  • (no location specified)
Aug 26, 2023

MDS Trial (Fasting-mimicking diet (FMD) and physiotherapy)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Fasting-mimicking diet (FMD) and physiotherapy
  • (no location specified)
Jun 22, 2022

MDS Patients Using Sequential Peripheral Blood Samples

Recruiting
  • Myelodysplastic Syndromes
    • Badalona, Barcelona, Spain
      Josep Carreras Leukaemia Research Institute
    Mar 8, 2022

    Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

    Recruiting
    • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
    • Ocala, Florida
    • +3 more
    Jan 30, 2023

    MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

    Completed
    Has Results
    • MDS
    • +2 more
    • Placebo
    • Romiplostim
    • (no location specified)
    Nov 4, 2022

    MDS Trial (Yisui granule, Placebo)

    Not yet recruiting
    • MDS
    • Yisui granule
    • Placebo
    • (no location specified)
    Jan 13, 2023

    MDS Trial (Imetelstat)

    Available
    • Myelodysplastic Syndromes
    • (no location specified)
    Jun 30, 2023

    Low Risk MDS Trial (R906289 Monosodium (R289 Na))

    Not yet recruiting
    • Low Risk Myelodysplastic Syndromes
    • R906289 Monosodium (R289 Na)
    • (no location specified)
    Jul 22, 2022

    Acute Myeloid Leukemia, MDS Trial in Hangzhou (Decitabine for Injection, VENCLYXTO)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Sep 18, 2023

    MDS Trial in Houston (Sertraline, Bone Marrow Aspirate/Biopsy)

    Terminated
    • Myelodysplastic Syndromes
    • Houston, Texas
    • +1 more
    May 31, 2022

    Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

    Recruiting
    • Leukemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Aug 23, 2022

    MDS, Thrombocytopenia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Thrombocytopenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 8, 2022

    MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Oral Azacitidine
    • Placebo for Oral Azacitidine
    • Buenos Aires, Argentina
    • +1 more
    Aug 1, 2022

    Anemia Trial (Luspatercept)

    Not yet recruiting
    • Anemia
    • Luspatercept
    • (no location specified)
    May 26, 2023

    Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

    Not yet recruiting
    • Clonal Cytopenia of Undetermined Significance
    • +4 more
    • Biospecimen Collection
    • +6 more
    • Los Angeles, California
    • +1 more
    Oct 4, 2023

    MDS Trial in Beijing (Hetrombopag, Stanozolol Tablets)

    Not yet recruiting
    • MDS
    • Beijing, China
      Peking Union Medical College Hospital
    Sep 18, 2021

    MDS (MDS) Trial in United Kingdom (Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol)

    Recruiting
    • Myelodysplastic Syndromes (MDS)
    • Sodium Valproate, Bezafibrate, Medroxyprogesterone
    • Danazol
    • Dudley, England, United Kingdom
    • +7 more
    Aug 12, 2022

    Anemia, MDS Trial in Germany (Canakinumab Injection)

    Recruiting
    • Anemia
    • Myelodysplastic Syndromes
    • Canakinumab Injection
    • Berlin, Germany
    • +5 more
    Nov 8, 2022

    MDS Trial in Worldwide (MBG453, NIS793, canakinumab)

    Recruiting
    • Myelodysplastic Syndromes
    • Duarte, California
    • +14 more
    Jan 23, 2023

    Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

    Completed
    Has Results
    • Anemia
    • +5 more
    • Denver, Colorado
    • +19 more
    Oct 20, 2022

    Serum Erythropoietin Level,Ferritin Level and Fibrinogen in

    Unknown status
    • MDS
    • (no location specified)
    Sep 28, 2020

    Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

    Completed
    • Anemia in Myelodysplastic Syndromes
    • Plantation, Florida
    • +2 more
    Apr 4, 2022

    MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)

    Active, not recruiting
    • Myelodysplastic Syndromes (MDS)
    • Acute Myelogenous Leukemia (AML)
    • low dose 5'-azacitidine
    • Basking Ridge, New Jersey
    • +6 more
    Dec 1, 2022

    MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Saint Louis, Missouri
    • +20 more
    Dec 28, 2022

    MDS, Chronic Myelomonocytic Leukemia-1, Cytopenia Trial in Denmark, United States (Vitamin C (ascorbic acid), Placebo)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Vitamin C (ascorbic acid)
    • Placebo
    • Los Angeles, California
    • +4 more
    Sep 27, 2021